News
A 4-point thrombocytopenia score was found able to rule out suspected HIT
January 11, 2021
A low score – 3 points or less – has a negative predictive value of 99.8%, “so HIT is basically ruled out.”
News
Cost is the main hurdle to broad use of caplacizumab for TTP
December 7, 2020
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said.
News
What to do when anticoagulation fails cancer patients
December 1, 2020
When it comes to “anticoagulation failure, we are entering an evidence free-zone.”
News
CMS launches hospital-at-home program to free up hospital capacity
December 1, 2020
The agency will be giving more flexibility to ambulatory surgery centers (ASCs) to provide hospital-level care.
News
Factor XI inhibitor–based anticoagulation strategies gain ground
November 18, 2020
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
News
COVID-19: Thromboembolic events high despite prophylaxis
October 27, 2020
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”
![1]()
Article
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate
October 20, 2020
Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival, comparable with the general population.
News
Blood group O linked to decreased risk of SARS-CoV-2 infection
October 15, 2020
A retrospective analysis of all Danish individuals with a known ABO blood group tested for SARS-CoV-2 showed a lower infection risk for SARS-CoV-2 infection in blood group O.
![1]()
News
INR fails to predict bleeding in patients with cirrhosis
October 6, 2020
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.
![1]()
News
No rise in major hemorrhagic events with antiplatelet therapy after ICH
August 3, 2020
Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming antiplatelet therapy following an ICH?
